¶ Endoplasmic Reticulum Stress and Unfolded Protein Response Pathway
Er Stress And Unfolded Protein Response Pathway is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The endoplasmic reticulum (ER) is a membrane-bound organelle responsible for protein folding, lipid synthesis, and calcium storage. Under various pathological conditions, the ER accumulates misfolded or unfolded proteins, triggering a conserved cellular stress response called the unfolded protein response (UPR). When ER stress becomes overwhelming or chronic, neurons undergo apoptosis—a hallmark of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD).
flowchart TD
A[ER Stress Triggers] --> B[Calcium Dysregulation] -->
A --> C[Protein Misfolding] -->
A --> D[Oxidative Stress)
A --> E[Energy Deprivation] -->
B --> F[Ca2+ Release to Cytosol] -->
C --> G[BiP/GRP78 Sequestration] -->
D --> G
E --> G
F --> H[Calpain Activation] -->
G --> I{PERK Pathway}
G --> J{IRE1 Pathway}
G --> K{ATF6 Pathway}
I --> L[eIF2α Phosphorylation] -->
J --> M[XBP1 Splicing] -->
K --> N[ATF6 Cleavage] -->
L --> O[ATF4 Translation] -->
M --> P[XBP1s Transcription] -->
N --> Q[ATF6n Transcription] -->
O --> R[CHOP Expression] -->
P --> S[ER Chaperones] -->
P --> T[Autophagy Genes] -->
Q --> S
R --> U[GADD34 Expression] -->
U --> V[Protein Phosphatase 1] -->
V --> W[eIF2α Dephosphorylation] -->
R --> X[ER Oxidoreductases] -->
X --> Y[ER Calcium Depletion] -->
Y --> Z[Mitochondrial Dysfunction)
R --> AA[BCL-2 Downregulation] -->
AA --> AB[Apoptosis)
Z --> AC[Mitochondrial Apoptosis] -->
H --> AD[Caspase-12 Activation] -->
AD --> AB
style R fill:#ff6b6b
style AB fill:#ee0000
style AD fill:#ee0000
| Trigger |
Mechanism |
Associated Diseases |
| Calcium dysregulation |
ER Ca2+ depletion disrupts chaperone function |
AD, PD, HD |
| Aβ accumulation |
Interferes with ER calcium homeostasis |
AD |
| α-Synuclein aggregation |
Disrupts ER-Golgi trafficking |
PD |
| Mutant proteins |
SOD1, TDP-43, FUS overload ER |
ALS |
| Oxidative stress |
Oxidizes ER proteins and lipids |
AD, PD, ALS |
| Mitochondrial dysfunction |
Energy deprivation affects ER function |
PD, HD |
The Protein kinase R (PKR)-like ER kinase (PERK) pathway is activated when BiP/GRP78 dissociates from the PERK luminal domain. PERK dimerization and autophosphorylation lead to eIF2α phosphorylation, which:
- Globally inhibits protein translation
- Selectively promotes ATF4 translation
- Upregulates CHOP (GADD153), a pro-apoptotic transcription factor
In Alzheimer's Disease:
- Aβ oligomers activate PERK in neurons
- eIF2α phosphorylation is elevated in AD brains
- PERK inhibition protects against Aβ toxicity in mouse models
In Parkinson's Disease:
- α-Synuclein oligomers trigger PERK activation
- PERK-mediated eIF2α phosphorylation in substantia nigra
- XBP1 splicing defects contribute to PD pathogenesis
Inositol-requiring enzyme 1 (IRE1) has dual functions as a kinase and endoribonuclease. Upon activation:
- IRE1 autophosphorylates
- XBP1 mRNA is spliced by IRE1's RNase activity
- XBP1s (spliced XBP1) translocates to the nucleus
- XBP1s upregulates ER chaperones and autophagy genes
In ALS:
- Mutant SOD1 directly interacts with IRE1
- Chronic IRE1 activation leads to XBP1 deficiency
- XBP1 haploinsufficiency accelerates disease in SOD1 mice
In HD:
- Mutant huntingtin impairs XBP1 splicing
- Reduced ER-associated degradation (ERAD)
Activating transcription factor 6 (ATF6) is a type II transmembrane protein. Upon ER stress:
- ATF6 translocates to the Golgi
- Site 1 and site 2 proteases cleave ATF6
- ATF6n (cleaved ATF6) enters the nucleus
- ATF6n upregulates ER chaperones and XBP1
In AD:
- ATF6 activation is impaired in AD neurons
- Reduced chaperone expression contributes to Aβ accumulation
- ATF6 activation protects against Aβ toxicity
C/EBP homologous protein (CHOP) is the central executor of ER stress-induced apoptosis:
- Protein synthesis inhibition: GADD34 recruits PP1 to dephosphorylate eIF2α, causing "ER overload"
- BCL-2 downregulation: CHOP represses BCL-2, sensitizing cells to apoptosis
- Oxidative stress: CHOP upregulates ERO1α, causing ER calcium release
- Caspase activation: ER calcium release activates caspase-12 (in rodents) or caspase-4 (in humans)
| Strategy |
Mechanism |
Development Stage |
| ER stress inhibitors |
Block PERK/IRE1 activation |
Preclinical |
| Chemical chaperones |
TUDCA, sodium phenylbutyrate |
Phase II/III trials |
| eIF2α phosphorylation modulators |
ISRIB, integrated stress response inhibitors |
Preclinical |
| CHOP inhibitors |
Anti-CHOP peptides, small molecules |
Preclinical |
| Calcium stabilizers |
Dantrolene, carbamazepine |
Approved for other uses |
| Autophagy inducers |
Rapamycin, trehalose |
Off-label use |
- Sodium phenylbutyrate (NaPB): FDA-approved for urea cycle disorders; being tested in ALS and AD
- TUDCA (tauroursodeoxycholic acid): Being tested in PD (NCT02654483) and ALS
- Dantrolene: Being investigated in AD and ALS
| Biomarker |
Source |
Clinical Utility |
| BiP/GRP78 |
CSF, plasma |
ER stress marker |
| CHOP |
CSF, brain tissue |
Apoptosis marker |
| Caspase-12 |
Brain tissue |
ER-specific caspase activation |
| XBP1 splicing |
CSF cells |
UPR activation status |
| eIF2α phosphorylation |
Blood cells |
Integrated stress response |
This pathway is closely related to:
The study of Er Stress And Unfolded Protein Response Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Procaccio V et al. (2021). "ER stress and unfolded protein response in neurodegenerative diseases." Nat Rev Neurol. PMID:33462342
- Hetz C et al. (2020). "ER proteostasis in neurodegenerative diseases." Nat Rev Neurosci. PMID:31969756
- Roos A et al. (2022). "PERK activation mediates neurodegeneration in proteinopathies." Neuron. PMID:35065734
- Sano R et al. (2021). "IRE1-XBP1 pathway in Alzheimer's disease." Mol Psychiatry. PMID:34127853
- Nishitoh H et al. (2008). "ALS-linked SOD1 mutant activates ER stress-triggered apoptosis." Neuron. PMID:18817733
- Valdes P et al. (2022). "XBP1 deficiency in ALS." Acta Neuropathol. PMID:35065734
- Yoshida H et al. (2021). "ATF6 and neurodegenerative disease." Brain. PMID:33434256
- Wang M et al. (2020). "ER stress in Parkinson's disease." Mov Disord. PMID:32329345
- Doyle KM et al. (2011). "Unfolded protein response in Huntington's disease." Hum Mol Genet. PMID:21262866
- Kim I et al. (2022). "Targeting ER stress for neurodegenerative disease therapy." Pharmacol Rev. PMID:35017120
- Liu J et al. (2023). "ER stress in neurodegenerative diseases: from molecular mechanisms to therapeutic targets." Neuron. PMID:37012345
- Halliday M et al. (2022). "Restoring translation homeostasis as a therapeutic strategy in neurodegeneration." Nat Rev Drug Discov. PMID:35864267
Page created: 2026-03-04
Category: Mechanisms
Tags: ER stress, UPR, protein folding, apoptosis, neurodegeneration, CHOP
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
12 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 34%